Background illustration for clinical trials search

Paid Clinical Trials Renton

Discover 1,461 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Daily Doxycycline for Early Syphillis

for
Syphilis
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06683638

Phase 2, Recruiting

Ocular Surface Dry Eye Microbiome

for
Dry Eyes
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT02306668

Recruiting

Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

for
Chalazion
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT02025023

Phase 3, Recruiting

"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"

for
Mycoplasma Genitalium, Non-gonococcal Urethritis (NGU)
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT07088419

Phase 2, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Issaquah WA, Seattle WA, Edmonds WA, Victoria, Kelowna,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Issaquah WA, Seattle WA, Edmonds WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase 2, Recruiting

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Issaquah WA, Seattle WA, Edmonds WA, Portland OR,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT06388018

Phase 2, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Issaquah WA, Seattle WA, Edmonds WA, Portland OR,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Issaquah WA, Seattle WA, Edmonds WA, Hood River OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase 3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Issaquah WA, Seattle WA, Edmonds WA, Portland OR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

for
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Location: Issaquah WA, Seattle WA, Edmonds WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04840602

Phase 2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Issaquah WA, Seattle WA, Edmonds WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase 2, Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Issaquah WA, Seattle WA, Edmonds WA, Vancouver WA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase 3, Recruiting

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

for
Lung Non-Small Cell Carcinoma
Location: Issaquah WA, Seattle WA, Edmonds WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07388524

Phase 3, Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for
Core Binding Factor Acute Myeloid Leukemia
Location: Issaquah WA, Seattle WA, Edmonds WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase 2, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Issaquah WA, Seattle WA, Edmonds WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase 2, Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

for
Metastatic Salivary Gland Carcinoma,
Location: Issaquah WA, Seattle WA, Fruitland ID, Nampa ID,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05408845

Phase 2, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Issaquah WA, Seattle WA, Edmonds WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase 2, Recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for
Breast Cancer
Location: Seattle WA, Tacoma WA, Edmonds WA, Everett WA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06790693

Phase 3, Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Issaquah WA, Seattle WA, Bellingham WA, Portland OR,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase 3, Recruiting